Development of spermatogonia and spermatocytes are the critical steps of spermatogenesis, impacting on male fertility. Investigation of the related regulators benefits the understanding of male reproduction. The proteasome system has been reported to regulate spermatogenesis, but the mechanisms and key contributing factors in vivo are poorly explored. Here we found that ablation of REGg, a proteasome activator, resulted in male subfertility. Analysis of the mouse testes after birth showed there was a decreased number of PLZF + spermatogonia and spermatocytes. Molecular analysis found that REGg loss significantly increased the abundance of p53 protein in the testis, and directly repressed PLZF transcription in cell lines. Of note, allelic p53 haplodeficiency partially rescued the defects in spermatogenesis observed in REGg-deficient mice. In summary, our results identify REGg-p53-PLZF to be a critical pathway that regulates spermatogenesis and establishes a new molecular link between the proteasome system and male reproduction.
INTRODUCTION
Spermatogenesis is a highly complex and organized process of sperm cell development (Walker, 2009) . It can broadly be categorized into three stages: the mitotic proliferation of spermatogonia, the meiotic division into haploid germ cells, and spermiogenic differentiation . Spermatogonial stem cells (SSCs) are critical for this whole process (Walker, 2009; Wang et al., 2016; Xu et al., 2017; Zhang et al., 2016; Zhou et al., 2016) . These SSCs undergo both selfrenewal and differentiating divisions and serve as the precursors to spermatozoa (Lovasco et al., 2015) . The ability of SSCs to self-renew is restricted to undifferentiated spermatogonia (Takubo et al., 2008) . Some transcription factors, such as PLZF, P53, Bcl6b, Lhx1, Etv5, and Id4, have been reported to regulate SSC self-renewal and proliferation (Beumer et al., 1998; Helsel et al., 2017; Kubota et al., 2004; La et al., 2018; Oatley et al., 2006) . PLZF (promyelocytic leukemia zinc finger, also known as Zfp145), a transcriptional repressor, regulates the epigenetic state of the undifferentiated spermatogonia and is directly involved in self-renewal and maintenance of the SSC pool (Buaas et al., 2004) . PLZF binds to DNA through nine Krüppel-like C2-H2 zinc fingers and an N-terminal BTB/POZ domain in a sequence-specific manner (Li et al., 1997) . Overexpression of PLZF induces cell-cycle arrest at the G1 to S transition and represses the expression of proproliferative genes, including cyclin A, CCNA2, and MYC (Costoya et al., 2008) . PLZF protein inactivates itself in an autologous feedback loop by binding to its promoter, causing rapid exhaustion of the proliferative spermatogonial compartment (Costoya et al., 2004; Filipponi et al., 2007) . Mice lacking PLZF show a progressive lack of spermatogonia in the tubules and impaired spermatogenesis, which consequently causes infertility (Buaas et al., 2004; Costoya et al., 2004; Filipponi et al., 2007; Hobbs et al., 2010) . Therefore, identification of PLZF regulatory mechanisms will help to understand the SSC fate decisions underlying male fertility.
The p53 family of genes (p53, p63, and p73) are transcription factors and regulate DNA repair, cell-cycle progression, and programmed cell death (Flores et al., 2002; Oren, 1994; Roos and Kaina, 2006) . p53 plays an important role in apoptosis during normal spermatogenesis and DNA quality control in spermatocytes (Baum et al., 2005; Beumer et al., 1998; Marcet-Ortega et al., 2017) . p53 knockout mice exhibited lower levels of DNA repair during spermatogenesis (Schwartz et al., 1999 ). Yet hyperactivation of p53 is detrimental to spermatogenesis as well (Fujisawa et al., 2001 ). Therefore, p53 seems to be a critical regulator of spermatogenesis; however, the direct mechanisms remain unclear.
REGg (also known as PA28g or PSME3) is a member of the 11S proteasome. REGg binds and activates the 20S proteasome to promote ATP-and ubiquitin-independent protein degradation, a non-typical degradation pathway (Li et al., 2006 (Li et al., , 2007 . Steroid receptor coactivator-3 was the first identified target of REGg in this non-typical degradation pathway (Li et al., 2006) . Since then, additional targets have been reported, such as the cyclin-dependent kinase inhibitor p21 (Chen et al., 2007; Li et al., 2007) , casein kinase (CK) 1d , SirT1 (Dong et al., 2013) , GSK-3b (Chen et al., 2017a (Chen et al., , 2017b Li et al., 2015) , hemoglobin (Zuo et al., 2017) , and IkB 3 . Of note, the degradation of p53, which is essential for spermatogenesis, also can be facilitated by REGg through MDM2-mediated ubiquitination Liu et al., 2010; Zhang and Zhang, 2008) . Meanwhile, REGg was found to be expressed in almost all cell types of the mouse testis, including spermatogonial cells, spermatocytes, Leydig cells, Sertoli cells, and spermatid cells . Interestingly, attenuated proteasome function, such as the knockout of proteasome activator PA200, resulted in defects in spermatogenesis (Khor et al., 2006) . However, complete infertility was only observed in double knockout mice in which both REGg and PA200 were ablated, but not in each single knockout mouse . These mouse phenotypes and REGg's regulation of p53 suggest that REGg may regulate male fertility by the regulation of spermatogenesis.
Herein we report the impact of the proteasome activator, REGg, for spermatogenesis. We used a mouse model as well as human and mouse cell lines to investigate the underlying mechanism of REGg deletion in spermatogenesis. We found that REGg knockout reduced male mouse fertility, with mice exhibiting defects in spermatogenesis. Defects include decreased numbers of PLZF-expressing spermatogonia. This appears to be due to the loss of negative regulation of p53 by REGg in REGg null mice. Furthermore, we showed that PLZF expression was negatively regulated by p53 at the transcriptional level in GC-1 cells. Notably, genetic attenuation of p53 partially restores spermatogenesis in REGg null mice. Taken as a whole, our results identify REGg as a critical factor required for normal PLZF-expressing spermatogonial stem cell representation and spermatogenesis, partially by regulation of the p53-PLZF pathway.
RESULTS

REGg Deficiency in Mouse Testes Decreases Sperm
Concentration and Activity, Causing Male Subfertility Previously we showed that REGg was ubiquitously present in nearly all mouse tissues, with especially high expression in testes . Here we examined REGg expression within the mouse testis by conducting immunohistochemical analyses of mouse testes at post-natal days 7 (P7) and 10 (P10) and at 2 months (2m). The P7 stage was chosen for the investigation of development defects preceding meiosis. The P10 stage was included because it is considered the initiation of meiosis. The 2-month stage represents reproductive maturity. REGg is expressed continuously in mouse testes during testis development ( Figures 1A and  S1A ). Interestingly, while REGg is expressed in many cell types in testes at 2m, expression at P7 and P10 was selectively detected in the subpopulation of cells near the basement membrane where spermatogonia are enriched ( Figure S1A ).
To investigate the role of REGg in male fertility, REGg S1C ), whereas the whole-body weight of REGg knockout mice was similar to that of wild-type mice ( Figure S1D ). H&E staining was conducted on testes from 2m ( Figure 1D ) and P7 and P10 ( Figure S1E ). Pathological phenotypes in REGg À/À mouse testes observed at 2m ( Figure 1D ) included an apparent decrease in the number of spermatogonial cells, primary spermatocytes, and spermatids, which was investigated further beginning with assessments of spermatogenic output. We collected sperm from REGg +/+ or REGg À/À littermate adults. REGg À/À mouse sperm concentrations were dramatically lower than the control mice ( Figure 1E ). Sperm motility was also attenuated in REGg À/À mice ( Figure 1F ). Figures 2E and 2F ). The expression of germ cell differentiation genes, Dazl, Scp2, and Scp3, was also decreased in REGg À/À testes ( Figure 2G ). Collectively these data suggest that the absence of REGg in mutant mice resulted in the decrease of spermatocytes in the seminiferous epithelium.
When REGg
REGg Loss Decreases the Number of PLZF +
Spermatogonial Cells
The decrease in spermatocytes undergoing meiosis in REGg À/À mice suggested potential defects in the early stages of spermatogenesis. To assess the development of spermatogonia, we investigated the expression of PLZF. PLZF is not only a well-known marker specific for undifferentiated spermatogonia in testis but also a critical regulator of germ cell development. In wild-type mouse testes, co-localization of REGg and PLZF was observed at P7 ( Figure 3A ) and P10 ( Figure S2A ), indicating that undifferentiated spermatogonia express REGg. Of note, loss of REGg resulted in a dramatic decrease of PLZF-expressing spermatogonial cells ( Figures 3A-3C ). In line with the histological staining results, a drastic reduction of PLZF was seen in whole-testis lysates of P7 REGg-deficient mice compared with the control ( Figure 3D ), and Plzf transcripts were also reduced ( Figure 3E ). Considering that we were using a developmental whole-animal knockout model, this decrease might be due to a defect earlier in germ cell development. Therefore, we observed PLZF expression just after birth (P1). The number of PLZF-expressing SSCs was decreased in P1 REGg-deficient mice compared with control ( Figure 3F ). At P10, PLZF and SCP3 staining were also reduced ( Figure 3G) ; however, the ratio of SCP3 + cells to PLZF + cells in REGg-deficient testes also indicates a decrease in the abundance of PLZFexpressing cells relative to SCP3-expressing cells compared with the wild-type group (Figures 3G and 3H) . This suggests that the decreased number of spermatocytes in REGg
mouse testes is because of fewer PLZF + spermatogonial cells, rather than a defect of meiosis. Furthermore, the expression of spermatogonial development marker genes, including Cd9, Nanos2, and Gfra1, was significantly lower in the REGg À/À testes at P7 ( Figure S2B ). Together, REGg loss leads to a reduced number of PLZF + spermatogonial cells in the postnatal testis. REGg is widely expressed in somatic cells and germ cells by 2m, and SSC development requires somatic niche factors including glial cell-derived neurotrophic factor (GDNF), which is produced by Sertoli cells, and signals through the SSC cell surface receptors RET and GFRa1 (Hofmann, 2008) . Therefore, the effect of REGg knockout on the expression of spermatogonial self-renewal factors that mediate GDNF signaling was examined. Each selfrenewal factor tested was downregulated after knockout of REGg ( Figure S2C ). Collectively, this indicates that the reduced SSC population in adult REGg knockout testes could result from non-cell-autonomous mechanisms Figure 3E (n = 3, **p < 0.01). Error bars represent mean ± SEM. (G) Real-time qRT-PCR analysis of marker gene expression in P10 REGg +/+ and REGg À/À male testes, using actin as the internal control (n = 3, **p < 0.01, ***p < 0.001). Error bars represent SEM (n = 3, **p < 0.01, p values were analyzed by two-way ANOVA).
(e.g., GDNF) in addition to disruption of cell-autonomous mechanisms.
P53 Binds to the PLZF Promoter and Negatively
Regulates PLZF The reduced PLZF mRNA expression in REGg À/À mouse testes ( Figure 3E) Figure 4A ). Considering that p53 is a well-proven target of REGg (Ali et al., 2013; Li et al., 2013; Liu et al., 2010) , and that p53 plays an essential role in spermatogenesis (Fujisawa et al., 2001) , we investigated potential p53-dependent regulation of Plzf. We transiently knocked down p53 in the C18-4 cell line (an SSC-derived mouse cell line). Of note, silencing p53 dramatically increased the intracellular mRNA level of Plzf ( Figure 4B ). We then generated a luciferase reporter driven by the Plzf promoter and tested the effect of p53 on Plzf-luciferase reporter expression in a p53-null cell line (H1299) with transfection of p53 or empty vector. As expected, expression of p53 drastically inhibited Plzf-luciferase activity ( Figure 4C ). We observed dose-dependent repression of Plzf-luciferase activity in response to p53 titration via transient transfection of H1299 cells, further confirming p53-mediated repression of Plzf ( Figure 4D ). Of note, this repression was abolished by the deletion of the -583 to -556 p53 response element within the Plzf promoter expressed in GC-1 spermatogonial-derived cells ( Figure 4E ). In response to Nutlin-3 (which acts as an inhibitor of the negative regulation of p53, leading to increased p53 activity), inhibition of the Plzf transcript was observed in A549 cells, which express wild-type p53 ( Figure 4F ). Chromatin immunoprecipitation (ChIP) assays showed that p53 bound to the Plzf proximal promoter in A549 cells on Nutlin-3 treatment ( Figure 4G ). To address whether p53 directly binds to the Plzf promoter in vivo, we performed ChIP assays using testes from cisplatin-treated REGg +/+ and REGg À/À littermates, and cisplatin was used to induce p53 expression. ChIP analysis indicated that p53 was recruited to the Plzf promoter region in both REGg +/+ and REGg À/À testes ( Figure 4H ).
Taken together, p53 inhibits PLZF at the transcriptional level by directly binding to the Plzf promoter.
Elevated p53 Is Associated with Spermatogonial Apoptosis in REGg À/À Testes Given our finding that p53 regulates Plzf, we continued to examine p53 protein expression during spermatogenesis. We speculated that p53 expression would be induced in mouse testes in the context of REGg knockout based on our previous observations that REGg promoted the degradation of p53 (Ali et al., 2013; Li et al., 2013; Liu et al., 2010) . As expected, a substantial increase of p53 was observed in REGg À/À testes at P7 ( Figure 5A ), P10 ( Figure S3A ), and 2m
( Figure S3B ) stages, while a decrease of REGg and PLZF was found. To determine whether REGg downregulates p53 protein levels in spermatogonia via proteasome degradation, overexpression of REGg in the presence of proteasome inhibition (e.g., MG132) in spermatogonia-derived GC1 cells was conducted ( Figure 5B ). REGg overexpression reduced the expression of p53, whereas this reduction was inhibited by MG132 treatment. Meanwhile, MG132 treatment increased p53 protein expression regardless of REGg or vector transfection, confirming the proteasome regulation of p53 expression in GC-1 cells. In contrast to the decrease of PLZF + cells at birth in REGg À/À mouse testes ( Figure 3F ), P53 expression was induced ( Figure 5C ). This raised the notion that accumulated p53 expression is a major contributor to the REGg-loss-induced developmental defect (e.g., loss of PLZF + cells and expression).
Increased p53 can induce cell apoptosis (Fridman and Lowe, 2003 (Figures 5D and 5E ). In addition, REGg depletion sensitized testes to cisplatin (an anti-cancer drug)-induced apoptosis, as demonstrated by the accumulation of a cleavage fragment of poly ADP-ribose polymerase ( Figure S3C ). Interestingly, the majority of TUNEL + cells were spermatocyte-like based on their localization near the base membrane and co-localization with a subset of SCP3 + cells ( Figure S3D ). Our data indicate that the molecular basis for REGg actions on spermatogenesis is mediated through regulation of p53 in testes. Figure 6A ). We next examined the later stages and effects, such as PLZF staining and fertility. Importantly, allelic p53 haplodeficiency led to an increase of PLZF expression at P1 ( Figure 6B ) and P10 ( Figure 6C ), as well as the increase of SCP3 + cells ( Figure 6D ). Figure 6E ).
Western blot analysis of whole testes also confirmed the increase of PZLF, and of p21 (a known p53 target) (Kachnic et al., 1999) , in p53 haplodeficient mouse testes (Figure 6F) . Similarly, the percent of primary spermatocytes was increased based on histomorphology (Figures 6G Figure 5F (n = 3, **p < 0.01, p values were analyzed by two-tailed t test).
and S4). Notably, the average number of pups per litter in p53
+/À /REGg À/À male mice was significantly higher than the control group by counting a total of 20 litters in each group ( Figure 6H ). Based on these observations, we conclude that REGg regulates spermatogenesis by modulating the p53-PLZF pathway in testes.
DISCUSSION
REGg has been reported to play important roles in multiple biological processes. However, its function in spermatogenesis is poorly understood. In this study, we reported that REGg deficiency leads to defects in spermatogenesis and male subfertility. Mechanistically, REGg appears to be required for the normal development of spermatogenesis by maintaining PLZF + SSCs via suppression of p53, which negatively regulates PLZF transcription (Figure 7 ). Our in vivo experiments showed that allelic p53 haplodeficiency in REGg-deficient mice partially rescued the spermatogenic defects in REGg À/À mice. Therefore, our study establishes REGg-p53-PLZF as a new pathway regulating spermatogenesis.
Our current results showed that a developmental defect in spermatogonia may be a major cause of attenuated spermatogenesis in REGg À/À mice. It is important to note that we also observed that typical spermatogonial self-renewal factors (e.g., Gdnf, Ret, and Gfra1 in Figure S2C) were downregulated after knockout of REGg. These results suggest that REGg regulates spermatogenesis through different pathways. The working model (Figure 7 ) will require testing in spermatogonia, because it remains uncertain how well the SV40-transformed spermatogonial GC1 cell line models spermatogonia. Because REGg was widely expressed in the adult testis and other tissues, the role of REGg in specific cells should be further investigated in the future. For example, crossing REGg floxed mice with Nanos3-Cre mice or Dhh-Cre mice could be used for the investigation of germ cells or Sertoli cells, respectively, and potential disruptions to the +/À REGg À/À or p53 +/+ REGg À/À male mice from littermates were bred with REGg +/+ female mice and the litter size was analyzed (n = 5, **p < 0.01, p values were analyzed by two-tailed t test).
hypothalamic-pituitary axis in REGg
À/À mice should be considered in future studies in addition to direct effects on testicular function and SSCs (Matson et al., 2011; Matsumoto and Bremner, 1987) . PLZF is an intrinsic factor, whose loss causes the progressive failure of SSC development in spermatogenesis (Buaas et al., 2004) . In our data, male mice lacking REGg undergo progressive testis atrophy and infertility with age, which is reminiscent of the testis phenotype in PLZF À/À mice. The loss of PLZF in differentiating spermatogonia observed in this study could suggest an imbalance in SSC fate decisions in REGg À/À mice consistent with the PLZF À/À mouse phenotype. This is supported by the decrease, in REGg À/À mice, of GDNF, Ret, and Gfra1, which are required for SSC development, and is also consistent with our previous finding that proteasome activities were decreased more dramatically in older REGg-deficient mice (Lv et al., 2016) . Considering that SSC maintenance is regulated by various factors other than PLZF, such as GDNF (Meng et al., 2000) , TAF4b, and Ngn3 (Buaas et al., 2004; Costoya et al., 2004; Falender et al., 2005) , other mechanisms of REGg loss leading to the decreased SSCs cannot be excluded. The tumor suppressor p53 has been implicated in the regulation of SSC proliferation and spermatogonial differentiation (Chen et al., 2012; Marcet-Ortega et al., 2017 ). In our current study, we uncover a new role for p53 function in spermatogenesis where p53 functions to transcriptionally repress PLZF by directly binding to the Plzf promoter. Interestingly, Choi et al. (2014) reported that PLZF repressed transcription of TP53 and also reduced p53 protein stability by ubiquitination. This indicates a regulatory loop between p53 and PLZF. In line with p53's role in cell apoptosis, we found that REGg knockout mice had more apoptotic cells in testes. Interestingly, the majority of TUNEL + cells were SCP3 + cells localized near the basement membrane. It is not clear if this indicates a delay in apoptosis until the meiotic prophase or the precocious expression of SCP-3, as has been seen in SSCs in other mutants. It is necessary to investigate which p53 downstream gene or pathway plays a critical role in the regulation of the apoptosis of spermatogonia and/or spermatocytes in future studies. In summary, genetic ablation of REGg in mice leads to the accumulated p53 protein, decreased PLZF expression and PLZF + SSCs, and germ cell defects, eventually causing male subfertility (Figure 7) . Therefore, our study identifies REGg as a key player in the regulation of SSCs and spermatogenesis, and deepens our understanding of the proteasome system in the regulation of reproduction. The clinical application of our findings, such as targeting the REGg-p53-PLZF pathway in human azoospermia, deserves further investigation and represents an attractive direction.
EXPERIMENTAL PROCEDURES
Mice Maintenance
REGg À/À mice with C57BL/6 genetic background were acquired from John J. Monaco (University of Cincinnati College of Medicine, Cincinnati, OH) (Barton et al., 2004) . P53 +/À C57BL/6 mice were purchased from the Model Animal Research Center of Nanjing University. Mice were bred in the Animal Core Facility by following procedures approved by the Institutional Animal Care and Use Committee of East China Normal University.
Measurement of Mouse Sperm Concentration and Sperm Motility
Epididymides from 8-to 10-week-old mice were placed in 500 mL pre-warmed sperm Preparation Medium (Origio, Måløv, Denmark) in a concave glass dish placed in a 37 C water bath for 5 min to fully release the sperm. Tissue fragments were removed, and the sperm-containing culture solution was aspirated using a very fine glass siphon and placed into an HTM-IVOS sperm viability meter. When the sperm concentration was high, samples were further diluted with the medium before performing the measurement using the default program of the machine. Plzf is transcribed and PLZF can function in germ cell development. REGg deficiency leads to the defect of germ cell development and male subfertility. Mechanistically, REGg loss results in the accumulation of p53 protein by disruption of REGg-mediated p53 protein degradation; this subsequently leads to the decreased expression of PLZF through p53 direct inhibition at the transcriptional level. The REGg-p53-PLZF regulatory pathway provides a new mechanism to understand the role of REGg in the regulation of spermatogenesis.
Male Fertility and Fertilization Competency
Continuous mating studies were performed to assess male fertility. Five male mice from each genotype of 8-10 weeks of age were mated to wild-type C57BL/6J females until each produced four litters. The number of pups in each litter was recorded for a total of 20 litters in each group. To further assess fertilization competency in REGg knockout males, we assessed fertilization competence by observing fertilization rates the day after the mating. Ten 8-to 10-week-old wild-type C57BL/6J female mice were injected with 5 U of pregnant mare serum gonadotropin per mouse. After 24 h, each mouse was injected with 5 U of human chorionic gonadotropin. After 8 h, they were mated with wild-type or REGg knockout males (five pairs for each genotype) overnight. Female mice were sacrificed by cervical dislocation the next morning. The oocytes and zygotes were collected and placed in human tubal fluid medium in a CO 2 cell culture incubator for 24 to 48 h. The proportion of fertilized eggs in the two-cell stage was then counted and statistical analysis (t test) was performed.
Antibodies, Cell Lines, and Transfections
The following primary antibodies were used: REGg antibody (Invitrogen, catalog no. 38-3900), p21 antibody (BD Pharmingen, catalog no. 556430), b-actin antibody (Sigma, catalog no. A5316), PLZF antibody (Santa Cruz, catalog no. sc-28319), p53 antibody (Novocastra Laboratories, NCL-p53-CM5p), SCP3 antibody (Abcam, catalog no. ab15093), MVH antibody (Abcam, catalog no. ab13840). C18-4 is a spermatogonial stem cell line with wild-type p53. H1299 is a lung cancer cell line without endogenous p53. A459 is a lung cancer cell line with wild-type p53. GC-1 is a spermatogonial-derived cell line. All the cells are from ATCC and cultured following ATCC standard protocols. The plasmids were transfected into cells using Lipofectamine 2000 (Invitrogen), and the construction of these plasmids is described in the related Experimental Procedures. Cell lysates were collected for protein examination 2 days after transfection. MG132 (10 mM) or Nutlin-3 (10 mM) was used to treat cells for 6 h, and 10 mg/kg of cisplatin was used to treat the mice for 24 h before the sacrifice.
DNA Flow Cytometry Analysis
Testes obtained from 8-to 10-week-old male mice were washed three times aseptically in DMEM. Sertoli cells were isolated from mouse testis biopsies using the two-step enzymatic digestion as follows. First, seminiferous tubules were obtained after being treated with an enzymatic solution containing collagenase type IV (2 mg/mL) and DNAse I (10 mg/mL) in DMEM/F12 at 37 C for 10 min. After washing to remove interstitial cells, Sertoli cells were obtained using second enzymatic digestion with 4 mg/mL collagenase IV, 2.5 mg/mL hyaluronidase (Sigma), 2 mg/mL trypsin (Sigma), and 1 mg/mL DNAse I, followed by differential plating. In brief, cell suspensions were seeded into culture plates in DMEM/F12 (Gibco) supplemented with 10% FBS and incubated at 34 C in 5% CO 2 for 3 h. Flow cytometry analysis of DNA content was conducted as described previously (Zhu and Gooderham, 2002) . In brief, cellular DNA content was determined by propidium iodide-staining flow cytometry. Seventy percent ethanol was used to fix cells at À20 C for 1 h. Cells were then resuspended to 1 mL using PBS containing propidium iodide (5 mg/mL) and RNase A (0.1 mg/mL). The suspensions were incubated at 37 C for 30 min. The ploidy determination of nuclei was estimated by flow cytometry DNA content.
RNAi and RNA Analyses
ON-TARGETplus TP53 smart pool small interfering RNAs (siRNAs) (L-003329-00-0005, Dharmacon) and ON-TARGETplus Non-targeting smart pool siRNAs (D-001810-10-05, Dharmacon) were transfected into cells using Lipofectamine RNAiMAX (Thermo Fisher Scientific, catalog no. 13778150) following the manufacturer's protocol. The final concentration was 30 nM. The cells were collected for assay after transfection of siRNA for 48 h. Total RNA was extracted from cells or testes (liquid nitrogen treatment) using TRIzol (Takara). Total RNA (2 mg) was reverse transcribed in a total volume of 20 mL, including 53 RT SuperMix (Vazyme, China), RNase free ddH 2 O and template RNA. Aliquots of the RT products were used for qRT-PCR analysis. Each reaction consisted of 10 mL of SYBR Green (1:60,000 final concentration), 0.8 mL of 40 nM sense and antisense primers, 0.8 mL of cDNA, and 8.36 mL of H 2 O, to a total volume of 20 mL. Each experiment was performed in duplicate and was repeated three times. RT-PCR used SYBR Green (Bio-Rad) or the Mx3005P-qRT-PCR system (Stratagene). The gene-specific primers were as follows: REGg sense primer: 5-ACA AGTGAGGCAGAAGAC-3; REGg antisense primer: 5-ATCATGGCTATTGGTGAG-3; PLZF sense primer: 5-TCAATGCGGTGCCCAGTTCTCA-3; PLZF antisense primer: 5-AGTGCGCTTTGTGCCTGAAAGC-3; b-actin sense primer: 5-CGTCATACTCCTGCTTGCTG-3; b-actin antisense primer: 5-GTACGCCAACACAGTGCTG-3.
Western Blotting Analysis
Protein samples were prepared using radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 5 mM EDTA, 1 mM Na 3 VO 4 , 5-10 mM NaF) and western blot analysis of proteins extracted from cells was performed as described previously (Li et al., 2007; Liu et al., 2017) . Equivalent amounts of total protein were separated in a 10% SDS-PAGE gel, and immunoblots were analyzed using primary antibodies specific for REGg, p21, p53, PLZF, MVH, SCP3, and b-actin (1:1,000 dilution) overnight. After incubation with a fluorescent-labeled secondary antibody (1:5,000 dilution), specific signals for proteins were visualized by an LI-COR Odyssey Infrared Imaging System.
Luciferase Assay
Cells were transfected with pGL3 luciferase PLZF, pGL3 luciferase PLZF deletion 583-556, or the pGL3-Basic vector and harvested after 36 h. The cells were washed with cold PBS three times after transfection for 24 h, then lysed in the lysis buffer provided with the Luciferase Assay Kit (Promega). After one cycle of freezing and thawing, the cell lysates were collected and centrifuged at 4 C at 12,000 3 g for 10 min. The supernatant was then collected, and 20 mL was added to an equal amount of luciferase assay substrate, twice for each lysate. Luminescence was measured as relative light units, and LUMIstar OPTIMA (BMG LABTECH) was used to take the reading of the luciferase assay. The primers to constructed pGL3 luciferase PLZF and pGL3 luciferase PLZF deletion 583-556 are as follows:
Each assay was repeated at least three times. Fold expression values were represented as the mean of the three experiments (Li et al., 2015) .
ChIP Assay
ChIP experiments were performed as described previously (Li et al., 2015) . Testes were lysed in RIPA lysis buffer. The lysates were then sonicated to result in DNA fragments of 200-1,000 bp in length. Cellular debris was removed by centrifugation and the lysates were diluted 1:10 in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM NaCl, protease inhibitors, and 16.7 mM Tris-HCl [pH 8.1]). The samples were immunoprecipitated with indicated antibodies (immunoglobulin G [IgG], p53) overnight. DNA-protein immunocomplexes were isolated with protein A agarose beads for 2 h. The beads were washed, eluted in 250 mL elution buffer (1% SDS and 100 mM NaHCO 3 ), and crosslinking was reversed by adding NaCl to a final concentration of 200 mM and incubating overnight. The DNA was recovered by phenol/chloroform/isoamyl alcohol (25/24/1) extractions and precipitated with 0.1 volume of 3 M sodium acetate (pH 5.2) and 2 volumes of ethanol using glycogen as a carrier. PCR amplification of the genomic fragments was performed with specific primers flanking putative binding sites on the PLZF promoter. The PCR products were electrophoresed in agarose gels and visualized by ethidium bromide. ChIP primer sequences are as follows: forward: 5-CTTAAGCGTGCAAGGACAGA-3; reverse: 5-TAAAAG TAAGAAGCATTCGGCT-3.
Immunohistochemistry, Immunofluorescence, and TUNEL Analyses
Testes were fixed in Bouin's solution overnight at room temperature and were then dehydrated through a graded series of ethanol and embedded in paraffin. For IHC analysis, slides were boiled in Buffer TE (10 mM Tris, 1 mM EDTA [pH 9.0]) for 20 min. After washing with PBS 3 times, the sections were permeated in H 2 O 2 for 10 min, blocked with 5% BSA in PBS for 10 min at room temperature, and incubated overnight at 4 C with the primary antibodies at different concentrations. Subsequently, following three washes with PBS, the slides were incubated for 1 h with biotinylated goat anti-rabbit antibody IgG and then for 30 min with streptavidin-horseradish peroxidase peroxidase. The color reaction product was visualized by using diaminobenzidine-H 2 O 2 as a substrate for peroxidase. All sections were counterstained with hematoxylin. For the immunofluorescence staining, dewax of the slides was performed as for the IHC steps. The rest of the steps were performed as described previously (Liu et al., 2010 (Liu et al., , 2015 . To generate the percent of SCP3 cells, SCP3 + cell counts were divided by PLZF + cells based on the positive staining per view. For TUNEL analysis, slides were permeabilized with 10 mg/mL proteinase K (prepared with 10 mM Tris/HCl, [pH 7.4] buffer) for 30 min. For the experimental group, a TUNEL reaction solution of 50 mL TdT and 450 mL of the fluorescein-labeled dUTP solution was used; the negative control group was incubated with 500 mL of fluoresceinlabeled dUTP solution only. After rinsing, 50 mL of the TUNEL reaction mixture was added to the experimental tissue samples (for the negative control group only about 50 mL of dUTP solution was added). The sections were placed in a wet box at 37 C for 1 h in the dark. Sections were counterstained with DAPI for 3-5 min and mounted in media (VECTASHIELD Antifade Mounting Mmedium, Vector Laboratories, Burlingame, CA) and coverslips.
Statistics
Quantitative data were displayed as mean ± SEM or SD of independent samples using Prism software (GraphPad software). Statistical analysis of values was performed using two-tailed Student's t test. 
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